CPBIO (03839) announced quarterly results

• RevenueUS$2.1bn
• Net profitUS$10.1M
• Profit attributable to ownersUS$9.4M
• Revenue YoY-34.6%
• Net profit YoY-49.2%
• Depreciation & amortisationHK$65.8M
• Capital expenditureHK$-44.3M
• Interest-bearing debtHK$3.3bn

Source CPBIO